Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patient Compliance × Diet Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 13 Breast Neoplasms 13 Colorectal Neoplasms 8 Obesity 7 Ovarian Neoplasms 6 Motor Activity 5 Malnutrition 5 Rectal Neoplasms 4 Polycystic Ovary Syndrome 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Radiation Injuries 3 Pancreatic Neoplasms 3 Overweight 3 Multiple Myeloma 3 Melanoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Weight Loss 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Glioblastoma 2

Interventions

Exercise 3 Patient Navigation 2 regorafenib 1 potassium oxonate 1 beta-Aminoethyl Isothiourea 1 Videotape Recording 1 Trastuzumab 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Self Care 1 Radiation 1 Psychosocial Intervention 1 Oxaliplatin 1 Ocoxin 1 Nutrition Assessment 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Motivational Interviewing 1 Metabolism 1 Lapatinib 1 Interviews as Topic 1 Diet Therapy 1 Diet 1 Cisplatin 1 Capecitabine 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06635005 2025-10-16

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡